driven by the PitchBook Platform
Provider of therapeutic services for the treatment of emergency stroke. The company develops the anti-GPVI antibody as a platelet-aggregation inhibitor for acute thrombotic pathologies.
You’re viewing a free company profile from the PitchBook Platform. To explore Acticor Biotech’s full profile, request a free trial.
2 Former Executives
© 2017 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.